NIRSEVIMAB

NIRSEVIMAB was reported 1793 times

These side effects are most commonly reported by patients taking NIRSEVIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 324
1 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 302
2 RESPIRATORY SYNCYTIAL VIRUS INFECTION 251
3 INCORRECT DOSE ADMINISTERED 234
4 BRONCHIOLITIS 157
5 PYREXIA 114
6 COUGH 112
7 EXTRA DOSE ADMINISTERED 84
8 EXPIRED PRODUCT ADMINISTERED 50
9 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 50
10 DYSPNOEA 46
11 WHEEZING 44
12 APNOEA 42
13 RASH 39
14 PRODUCT STORAGE ERROR 38
15 RHINITIS 37
16 OXYGEN THERAPY 35
17 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 34
18 RESPIRATORY DISTRESS 33
19 RHINORRHOEA 31
20 WRONG PRODUCT ADMINISTERED 31
21 POOR FEEDING INFANT 28
22 VOMITING 28
23 VACCINATION FAILURE 27
24 URTICARIA 26
25 CYANOSIS 23
26 INFANTILE APNOEA 23
27 PNEUMONIA 22
28 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 22
29 DIARRHOEA 20
30 OXYGEN SATURATION DECREASED 20
31 UNDERDOSE 20
32 BRONCHITIS 19
33 TACHYPNOEA 19
34 DECREASED APPETITE 18
35 RESPIRATORY FAILURE 18
36 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 18
37 SYRINGE ISSUE 18
38 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17
39 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17
40 HYPOXIA 16
41 OVERDOSE 16
42 PRODUCT USE ISSUE 16
43 HAEMATOCHEZIA 15
44 HYPOTONIA 15
45 MATERNAL EXPOSURE DURING PREGNANCY 15
46 NASOPHARYNGITIS 15
47 PRODUCT DISPENSING ERROR 15
48 SEIZURE 15
49 CRYING 14
50 FATIGUE 14
51 SOMNOLENCE 14
52 ACCIDENTAL OVERDOSE 13
53 BRADYCARDIA 13
54 IMMUNE THROMBOCYTOPENIA 13
55 LOWER RESPIRATORY TRACT INFECTION 13
56 NASAL CONGESTION 13
57 OFF LABEL USE 13
58 ACUTE RESPIRATORY FAILURE 12
59 BRADYCARDIA NEONATAL 12
60 DEATH 12
61 HYPOPHAGIA 12
62 LETHARGY 12
63 PALLOR 12
64 POLYMERASE CHAIN REACTION POSITIVE 12
65 RESPIRATORY ARREST 12
66 RHINOVIRUS INFECTION 12
67 ANAEMIA 11
68 CONDITION AGGRAVATED 11
69 DOSE CALCULATION ERROR 11
70 ERYTHEMA 11
71 IRRITABILITY 11
72 UNRESPONSIVE TO STIMULI 11
73 COVID-19 10
74 ENTERAL NUTRITION 10
75 GASTROINTESTINAL TUBE INSERTION 10
76 INFLUENZA 10
77 NEONATAL HYPOXIA 10
78 PETECHIAE 10
79 POOR QUALITY PRODUCT ADMINISTERED 10
80 USE OF ACCESSORY RESPIRATORY MUSCLES 10
81 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10
82 PRODUCTIVE COUGH 9
83 RESPIRATORY TRACT INFECTION 9
84 THROMBOCYTOPENIA 9
85 ASTHMA 8
86 C-REACTIVE PROTEIN INCREASED 8
87 CARDIAC ARREST 8
88 DEPENDENCE ON OXYGEN THERAPY 8
89 FEEDING DISORDER 8
90 RESPIRATION ABNORMAL 8
91 SWELLING 8
92 BREATH SOUNDS ABNORMAL 7
93 BRIEF RESOLVED UNEXPLAINED EVENT 7
94 FEBRILE CONVULSION 7
95 FOETAL EXPOSURE DURING PREGNANCY 7
96 ILLNESS 7
97 INFECTION 7
98 NO ADVERSE EVENT 7
99 RALES 7
100 UPPER RESPIRATORY TRACT INFECTION 7
101 ASTHENIA 6
102 DYSKINESIA 6
103 ERYTHEMA MULTIFORME 6
104 EXPOSURE DURING PREGNANCY 6
105 EYE MOVEMENT DISORDER 6
106 GENERAL PHYSICAL HEALTH DETERIORATION 6
107 HYPERPYREXIA 6
108 HYPOTONIC-HYPORESPONSIVE EPISODE 6
109 INJECTION SITE INDURATION 6
110 KAWASAKI^S DISEASE 6
111 MALAISE 6
112 NEUTROPENIA 6
113 OPISTHOTONUS 6
114 PRODUCT PRESCRIBING ISSUE 6
115 RASH MACULAR 6
116 RESPIRATORY DISORDER 6
117 SCREAMING 6
118 SUDDEN INFANT DEATH SYNDROME 6
119 VIRAL INFECTION 6
120 ACCIDENTAL EXPOSURE TO PRODUCT 5
121 ACUTE RESPIRATORY DISTRESS SYNDROME 5
122 FEELING ABNORMAL 5
123 GASTROENTERITIS 5
124 HYPERBILIRUBINAEMIA 5
125 INJECTION SITE ERYTHEMA 5
126 INJECTION SITE SWELLING 5
127 JAUNDICE 5
128 LOSS OF CONSCIOUSNESS 5
129 LYMPHADENOPATHY 5
130 MENINGITIS 5
131 MUSCULOSKELETAL STIFFNESS 5
132 MYELOSUPPRESSION 5
133 RASH ERYTHEMATOUS 5
134 SUPRAVENTRICULAR TACHYCARDIA 5
135 VACCINATION ERROR 5
136 BRONCHOPULMONARY DYSPLASIA 4
137 CARDIO-RESPIRATORY ARREST 4
138 CATARRH 4
139 CHILLS 4
140 CIRCULATORY COLLAPSE 4
141 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4
142 CONJUNCTIVITIS 4
143 DEHYDRATION 4
144 FEELING HOT 4
145 FLATULENCE 4
146 GASTROINTESTINAL DISORDER 4
147 GENERALISED TONIC-CLONIC SEIZURE 4
148 HYPERSENSITIVITY 4
149 HYPOTHERMIA 4
150 HYPOTONIA NEONATAL 4
151 INFANT IRRITABILITY 4
152 INJECTION SITE PAIN 4
153 INJECTION SITE RASH 4
154 INJECTION SITE REACTION 4
155 INSOMNIA 4
156 LOWER RESPIRATORY TRACT INFECTION VIRAL 4
157 MUCOUS STOOLS 4
158 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4
159 NEONATAL RESPIRATORY DISTRESS 4
160 OTITIS MEDIA 4
161 PRODUCT PRESCRIBING ERROR 4
162 PRODUCT SELECTION ERROR 4
163 PULMONARY HAEMORRHAGE 4
164 RASH PAPULAR 4
165 SKIN DISCOLOURATION 4
166 SLEEP DISORDER 4
167 TACHYCARDIA 4
168 THERAPEUTIC RESPONSE DECREASED 4
169 TRANSAMINASES INCREASED 4
170 TREATMENT FAILURE 4
171 WRONG SCHEDULE 4
172 ABDOMINAL DISTENSION 3
173 ABNORMAL FAECES 3
174 ACUTE HEPATIC FAILURE 3
175 ADENOVIRUS INFECTION 3
176 AMMONIA INCREASED 3
177 ANGIOEDEMA 3
178 ASCITES 3
179 ATELECTASIS 3
180 BLOOD GLUCOSE DECREASED 3
181 BLOOD LACTIC ACID INCREASED 3
182 BODY TEMPERATURE INCREASED 3
183 BRAIN INJURY 3
184 BRONCHOSPASM 3
185 CARDIAC MURMUR 3
186 CHOKING 3
187 COAGULOPATHY 3
188 CREPITATIONS 3
189 CROUP INFECTIOUS 3
190 CYTOMEGALOVIRUS TEST POSITIVE 3
191 CYTOMEGALOVIRUS VIRAEMIA 3
192 DEPRESSED LEVEL OF CONSCIOUSNESS 3
193 DEVICE ISSUE 3
194 DISSEMINATED INTRAVASCULAR COAGULATION 3
195 DRUG INTERACTION 3
196 EAR INFECTION 3
197 EATING DISORDER 3
198 ECZEMA 3
199 FAECES DISCOLOURED 3
200 FEBRILE NEUTROPENIA 3
201 FLUID INTAKE REDUCED 3
202 FONTANELLE BULGING 3
203 FREQUENT BOWEL MOVEMENTS 3
204 HEPATITIS 3
205 HEPATOSPLENOMEGALY 3
206 HUMAN RHINOVIRUS TEST POSITIVE 3
207 HYPOTENSION 3
208 INFANTILE SPASMS 3
209 INFANTILE SPITTING UP 3
210 INHIBITORY DRUG INTERACTION 3
211 INJECTION SITE VESICLES 3
212 INTRAVENTRICULAR HAEMORRHAGE 3
213 INTUSSUSCEPTION 3
214 IRREGULAR BREATHING 3
215 LACRIMATION INCREASED 3
216 LEUKOPENIA 3
217 METABOLIC ACIDOSIS 3
218 METAPNEUMOVIRUS BRONCHIOLITIS 3
219 METAPNEUMOVIRUS INFECTION 3
220 MOUTH HAEMORRHAGE 3
221 MOUTH ULCERATION 3
222 MUSCLE TWITCHING 3
223 NEONATAL DYSPNOEA 3
224 NEONATAL SEIZURE 3
225 OEDEMA 3
226 PRODUCT ADMINISTRATION ERROR 3
227 PRODUCT USE IN UNAPPROVED INDICATION 3
228 RASH MACULO-PAPULAR 3
229 RHONCHI 3
230 SARS-COV-2 TEST POSITIVE 3
231 SEPSIS 3
232 STRIDOR 3
233 SUPERINFECTION BACTERIAL 3
234 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
235 TREMOR 3
236 VITAL FUNCTIONS ABNORMAL 3
237 WEIGHT DECREASED 3
238 ACCELERATED IDIOVENTRICULAR RHYTHM 2
239 ACUTE KIDNEY INJURY 2
240 ADVERSE EVENT 2
241 ADVERSE EVENT FOLLOWING IMMUNISATION 2
242 AGITATION 2
243 ANTIVIRAL PROPHYLAXIS 2
244 APATHY 2
245 APLASTIC ANAEMIA 2
246 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2
247 BLOOD SMEAR TEST ABNORMAL 2
248 CARDIAC FAILURE 2
249 CEREBRAL HAEMORRHAGE NEONATAL 2
250 CEREBRAL VENOUS SINUS THROMBOSIS 2
251 CHILDHOOD ASTHMA 2
252 CONJUNCTIVAL HYPERAEMIA 2
253 CONSTIPATION 2
254 CORONAVIRUS INFECTION 2
255 CYANOSIS NEONATAL 2
256 DEATH NEONATAL 2
257 DERMATITIS ATOPIC 2
258 DEVICE DEFECTIVE 2
259 DISCOMFORT 2
260 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2
261 DRUG MONITORING PROCEDURE NOT PERFORMED 2
262 DYSCHEZIA 2
263 DYSPHAGIA 2
264 EPISTAXIS 2
265 ERYSIPELAS 2
266 ERYTHEMA OF EYELID 2
267 ESCHERICHIA PYELONEPHRITIS 2
268 ESCHERICHIA SEPSIS 2
269 ESCHERICHIA TEST POSITIVE 2
270 EXPOSURE TO SARS-COV-2 2
271 EXPOSURE VIA SKIN CONTACT 2
272 EYE DISCHARGE 2
273 FAILURE TO THRIVE 2
274 FEELING JITTERY 2
275 FLUSHING 2
276 FOAMING AT MOUTH 2
277 FOOD REFUSAL 2
278 GASTROINTESTINAL HAEMORRHAGE 2
279 GASTROOESOPHAGEAL REFLUX DISEASE 2
280 GAZE PALSY 2
281 HAEMANGIOMA 2
282 HAEMATEMESIS 2
283 HEPATIC FUNCTION ABNORMAL 2
284 HEPATOMEGALY 2
285 HOSPITALISATION 2
286 HUMAN BOCAVIRUS INFECTION 2
287 HYPERAESTHESIA 2
288 HYPERSOMNIA 2
289 HYPERTONIA 2
290 HYPOKINESIA NEONATAL 2
291 HYPOPNOEA 2
292 HYPORESPONSIVE TO STIMULI 2
293 HYPOTHERMIA NEONATAL 2
294 IMMATURE PLATELET FRACTION INCREASED 2
295 IMMUNISATION REACTION 2
296 INCORRECT DOSAGE ADMINISTERED 2
297 INCORRECT PRODUCT ADMINISTRATION DURATION 2
298 INFLUENZA A VIRUS TEST POSITIVE 2
299 INFLUENZA LIKE ILLNESS 2
300 INJECTION SITE WARMTH 2
301 INTERCEPTED PRODUCT PRESCRIBING ERROR 2
302 JAUNDICE NEONATAL 2
303 LARYNGITIS 2
304 LEUKOCYTOSIS 2
305 LIP ERYTHEMA 2
306 LIP SWELLING 2
307 MATERNAL DRUGS AFFECTING FOETUS 2
308 MENINGOCOCCAL SEPSIS 2
309 MUCOSAL INFLAMMATION 2
310 NASAL OBSTRUCTION 2
311 NEEDLE ISSUE 2
312 NEONATAL RESPIRATORY ARREST 2
313 NEONATAL TACHYPNOEA 2
314 NEURODERMATITIS 2
315 NONSPECIFIC REACTION 2
316 OCULAR HYPERAEMIA 2
317 OEDEMA PERIPHERAL 2
318 OLIGURIA 2
319 OMPHALITIS 2
320 OPHTHALMIA NEONATORUM 2
321 OROPHARYNGEAL ERYTHEMA 2
322 OXYGEN SATURATION ABNORMAL 2
323 PAPULE 2
324 PARAINFLUENZAE VIRUS INFECTION 2
325 PERIPHERAL COLDNESS 2
326 PLATELET TRANSFUSION 2
327 PLEURAL EFFUSION 2
328 PNEUMONIA PNEUMOCOCCAL 2
329 PRESCRIBED OVERDOSE 2
330 PRESCRIBED UNDERDOSE 2
331 PRODUCT SUBSTITUTION ISSUE 2
332 PULMONARY OEDEMA 2
333 RECTAL HAEMORRHAGE 2
334 RED BLOOD CELL TRANSFUSION 2
335 RESPIRATORY RATE INCREASED 2
336 RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION 2
337 RESPIRATORY TRACT CONGESTION 2
338 SALIVARY HYPERSECRETION 2
339 SEPSIS NEONATAL 2
340 SINUS BRADYCARDIA 2
341 SOPOR 2
342 STERILE PYURIA 2
343 STREPTOCOCCUS TEST POSITIVE 2
344 SWELLING FACE 2
345 SWELLING OF EYELID 2
346 THERAPY CHANGE 2
347 TONSILLITIS 2
348 TORTICOLLIS 2
349 UMBILICAL HERNIA 2
350 URINARY TRACT INFECTION 2
351 VACCINATION COMPLICATION 2
352 VACCINATION SITE ERYTHEMA 2
353 VACCINATION SITE VESICLES 2
354 VASCULITIS 2
355 VENOOCCLUSIVE DISEASE 2
356 ABDOMINAL PAIN 1
357 ACCIDENTAL EXPOSURE TO PRODUCT BY ELDERLY PERSON 1
358 ACUTE HAEMORRHAGIC OEDEMA OF INFANCY 1
359 ALLERGY TO VACCINE 1
360 ANAPHYLACTIC REACTION 1
361 ANTIBODY-DEPENDENT ENHANCEMENT 1
362 ANURIA 1
363 ANXIETY 1
364 APNOEIC ATTACK 1
365 APPLICATION SITE ERYTHEMA 1
366 APPLICATION SITE REACTION 1
367 APPLICATION SITE SWELLING 1
368 ARRHYTHMIA 1
369 AUSCULTATION 1
370 BACTERIAL DACRYOCYSTITIS 1
371 BEHAVIOUR DISORDER 1
372 BLEPHARITIS 1
373 BLEPHAROSPASM 1
374 BLISTER 1
375 BLOOD BILIRUBIN INCREASED 1
376 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
377 BLOOD DISORDER 1
378 BLOOD FIBRINOGEN DECREASED 1
379 BLOOD IMMUNOGLOBULIN G DECREASED 1
380 BLOOD LACTATE DEHYDROGENASE INCREASED 1
381 BLOOD PRESSURE DECREASED 1
382 BODY TEMPERATURE FLUCTUATION 1
383 BRADYPNOEA 1
384 BRONCHIAL HYPERREACTIVITY 1
385 BRONCHIAL OBSTRUCTION 1
386 BRONCHITIS VIRAL 1
387 BRONCHOSTENOSIS 1
388 CARDIAC ARREST NEONATAL 1
389 CARDIAC DISORDER 1
390 CARDIO-RESPIRATORY DISTRESS 1
391 CEREBRAL ARTERY OCCLUSION 1
392 CEREBRAL HAEMORRHAGE 1
393 CEREBROVASCULAR ACCIDENT 1
394 CHRONIC KIDNEY DISEASE 1
395 COLITIS 1
396 CONGENITAL FIBROSARCOMA 1
397 CONTRAINDICATION TO VACCINATION 1
398 CONTUSION 1
399 CORNEAL OEDEMA 1
400 DEMYELINATION 1
401 DEPRESSED MOOD 1
402 DERMATITIS EXFOLIATIVE GENERALISED 1
403 DEVICE DISLOCATION 1
404 DEVICE LEAKAGE 1
405 DEVICE MALFUNCTION 1
406 DEVICE PHYSICAL PROPERTY ISSUE 1
407 DEVICE USE ISSUE 1
408 DIALYSIS 1
409 DIZZINESS 1
410 DRUG ADMINISTERED IN WRONG DEVICE 1
411 DRUG DELIVERY SYSTEM MALFUNCTION 1
412 DRUG EFFECT LESS THAN EXPECTED 1
413 DRUG HYPERSENSITIVITY 1
414 DRY SKIN 1
415 DUPLICATE THERAPY ERROR 1
416 DYSPHONIA 1
417 DYSPLASIA 1
418 EAR CONGESTION 1
419 ECCHYMOSIS 1
420 ENCEPHALITIS 1
421 ENTEROBACTER TEST POSITIVE 1
422 ENTEROVIRUS INFECTION 1
423 ENTEROVIRUS TEST POSITIVE 1
424 EOSINOPHILIA 1
425 EPILEPSY 1
426 ESCHERICHIA BACTERAEMIA 1
427 EXPOSURE VIA BREAST MILK 1
428 EXTRAPYRAMIDAL DISORDER 1
429 EYE SWELLING 1
430 EYELID MARGIN CRUSTING 1
431 EYELID RASH 1
432 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 1
433 FIBRIN D DIMER 1
434 FLAIL CHEST 1
435 GASTROENTERITIS ROTAVIRUS 1
436 GASTROENTERITIS VIRAL 1
437 GENERALISED OEDEMA 1
438 H3N2 INFLUENZA 1
439 HAEMANGIOMA-THROMBOCYTOPENIA SYNDROME 1
440 HAEMATOCRIT DECREASED 1
441 HAEMOGLOBIN DECREASED 1
442 HAEMOPHILUS TEST POSITIVE 1
443 HAEMORRHAGE 1
444 HAEMORRHAGE INTRACRANIAL 1
445 HAEMORRHAGIC STROKE 1
446 HCOV-OC43 INFECTION 1
447 HEART RATE DECREASED 1
448 HEART RATE INCREASED 1
449 HEMICLONIC SEIZURE 1
450 HEPATIC CYTOLYSIS 1
451 HEPATIC ENZYME INCREASED 1
452 HEPATIC FAILURE 1
453 HERPES SIMPLEX SEPSIS 1
454 HICCUPS 1
455 HYDROCEPHALUS 1
456 HYPERAEMIA 1
457 HYPERFERRITINAEMIA 1
458 HYPERGLYCAEMIA 1
459 HYPERURICAEMIA 1
460 HYPOGLYCAEMIA 1
461 HYPOKINESIA 1
462 HYPONATRAEMIA 1
463 HYPOTHYROIDISM 1
464 HYPOVOLAEMIA 1
465 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1
466 IMMUNISATION 1
467 IMPAIRED QUALITY OF LIFE 1
468 IMPETIGO 1
469 INCORRECT DOSE ADMINISTERED BY DEVICE 1
470 INCREASED APPETITE 1
471 INCREASED TENDENCY TO BRUISE 1
472 INCREASED UPPER AIRWAY SECRETION 1
473 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1
474 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
475 INFLAMMATORY MARKER INCREASED 1
476 INJECTION SITE INFLAMMATION 1
477 INJECTION SITE NODULE 1
478 INJECTION SITE URTICARIA 1
479 INJURY ASSOCIATED WITH DEVICE 1
480 INTELLECTUAL DISABILITY 1
481 INTENTIONAL PRODUCT USE ISSUE 1
482 INTERCEPTED PRODUCT STORAGE ERROR 1
483 INTERSTITIAL LUNG DISEASE 1
484 KAPOSIFORM HAEMANGIOENDOTHELIOMA 1
485 LARYNGOMALACIA 1
486 LIVER TRANSPLANT REJECTION 1
487 LIVIDITY 1
488 LOCALISED INFECTION 1
489 LOCALISED OEDEMA 1
490 LOWER RESPIRATORY TRACT CONGESTION 1
491 LUNG ABSCESS 1
492 LUNG DISORDER 1
493 LUNG INFILTRATION 1
494 LYMPHOPENIA 1
495 MACULE 1
496 MASS 1
497 MATERNAL EXPOSURE TIMING UNSPECIFIED 1
498 MENINGITIS PNEUMOCOCCAL 1
499 MENINGITIS VIRAL 1
500 MENTAL IMPAIRMENT 1
501 MILIARIA 1
502 MILK ALLERGY 1
503 MORAXELLA INFECTION 1
504 MOTOR DYSFUNCTION 1
505 MOVEMENT DISORDER 1
506 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1
507 MUSCLE RIGIDITY 1
508 MYCOPLASMA TEST POSITIVE 1
509 MYOCLONUS 1
510 MYOPATHY 1
511 MYOSITIS 1
512 NASOGASTRIC OUTPUT ABNORMAL 1
513 NECROTISING ENTEROCOLITIS NEONATAL 1
514 NEONATAL DISORDER 1
515 NEONATAL RESPIRATORY DISTRESS SYNDROME 1
516 NERVOUS SYSTEM DISORDER 1
517 NODULE 1
518 NON-EPILEPTIC PAROXYSMAL EVENT 1
519 NORMAL NEWBORN 1
520 NYSTAGMUS 1
521 OBSTRUCTIVE AIRWAYS DISORDER 1
522 OCCUPATIONAL EXPOSURE TO PRODUCT 1
523 OESOPHAGEAL ATRESIA 1
524 ORAL CANDIDIASIS 1
525 ORAL MUCOSAL EXFOLIATION 1
526 OSTEOMYELITIS 1
527 OTITIS MEDIA ACUTE 1
528 PAIN IN EXTREMITY 1
529 PALPABLE PURPURA 1
530 PARECHOVIRUS INFECTION 1
531 PARTIAL SEIZURES 1
532 PARVOVIRUS B19 INFECTION 1
533 PATHOGEN RESISTANCE 1
534 PERICARDIAL EFFUSION 1
535 PERINATAL STROKE 1
536 PERIORBITAL OEDEMA 1
537 PERIORBITAL SWELLING 1
538 PETIT MAL EPILEPSY 1
539 PHARYNGITIS 1
540 PHYSICAL PRODUCT LABEL ISSUE 1
541 PLAGIOCEPHALY 1
542 PLATELET COUNT DECREASED 1
543 PLEURAL DISORDER 1
544 PNEUMONIA BACTERIAL 1
545 PNEUMONIA MYCOPLASMAL 1
546 POSITIVE AIRWAY PRESSURE THERAPY 1
547 POST PROCEDURAL COMPLICATION 1
548 POST VACCINATION SYNDROME 1
549 POST-TUSSIVE VOMITING 1
550 POSTICTAL STATE 1
551 POSTURE ABNORMAL 1
552 POSTURING 1
553 PREMATURE BABY 1
554 PREMATURE LABOUR 1
555 PRESYNCOPE 1
556 PROCTITIS 1
557 PRODUCT COMMUNICATION ISSUE 1
558 PRODUCT DISPENSING ISSUE 1
559 PRODUCT DOSE CONFUSION 1
560 PRODUCT KNOWLEDGE DEFICIT 1
561 PRODUCT LABEL CONFUSION 1
562 PRODUCT PACKAGING ISSUE 1
563 PRODUCT PHYSICAL ISSUE 1
564 PRODUCT PREPARATION ERROR 1
565 PROLONGED EXPIRATION 1
566 PROTHROMBIN LEVEL INCREASED 1
567 PULMONARY ALVEOLAR HAEMORRHAGE 1
568 PULMONARY CONGESTION 1
569 PULMONARY EMBOLISM 1
570 PULMONARY VALVE THICKENING 1
571 PULSE ABSENT 1
572 PUPILLARY DISORDER 1
573 PURPURA 1
574 PYELONEPHRITIS ACUTE 1
575 PYLORIC STENOSIS 1
576 RASH NEONATAL 1
577 RASH PRURITIC 1
578 RASH VESICULAR 1
579 REACTION TO PREVIOUS EXPOSURE TO ANY VACCINE 1
580 REGURGITATION 1
581 RENAL FAILURE 1
582 RENAL IMPAIRMENT 1
583 RESPIRATORY ACIDOSIS 1
584 RESPIRATORY DEPRESSION 1
585 RESUSCITATION 1
586 RETICULOCYTE COUNT INCREASED 1
587 ROTAVIRUS INFECTION 1
588 SECRETION DISCHARGE 1
589 SEIZURE LIKE PHENOMENA 1
590 SELECTIVE EATING DISORDER 1
591 SKIN EXFOLIATION 1
592 SKIN INFECTION 1
593 SKIN LESION 1
594 SKIN REACTION 1
595 SKIN WARM 1
596 SNEEZING 1
597 SNORING 1
598 SPUTUM INCREASED 1
599 STAPHYLOCOCCAL INFECTION 1
600 STAPHYLOCOCCAL SKIN INFECTION 1
601 STARING 1
602 STATUS EPILEPTICUS 1
603 STREPTOCOCCAL INFECTION 1
604 SUBDURAL HAEMATOMA 1
605 SUDDEN DEATH 1
606 SWOLLEN TONGUE 1
607 SYNCOPE 1
608 THERAPEUTIC PRODUCT EFFECT DECREASED 1
609 THERAPEUTIC PRODUCT INEFFECTIVE 1
610 THERAPY INTERRUPTED 1
611 THERAPY NON-RESPONDER 1
612 TONIC POSTURING 1
613 TOXIC SKIN ERUPTION 1
614 TRANSCRIPTION MEDICATION ERROR 1
615 TYMPANIC MEMBRANE HYPERAEMIA 1
616 ULCER 1
617 UMBILICAL GRANULOMA 1
618 UNDERWEIGHT 1
619 UNKNOWN SCHEDULE OF PRODUCT ADMINISTRATION 1
620 UPPER AIRWAY OBSTRUCTION 1
621 VACCINATION SITE DISCOLOURATION 1
622 VACCINATION SITE INFLAMMATION 1
623 VACCINATION SITE OEDEMA 1
624 VACCINATION SITE REACTION 1
625 VACCINATION SITE SWELLING 1
626 VARICELLA VIRUS TEST POSITIVE 1
627 VIRAL RASH 1
628 VIRAL TRACHEITIS 1
629 WALKING AID USER 1
630 WOUND SECRETION 1
631 WRONG DOSE 1
632 WRONG PATIENT RECEIVED PRODUCT 1